P

Inventor

REYNOLDS CHARLES H

US45 patents
⚠️ This page may combine multiple inventors who share the name “REYNOLDS CHARLES H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHY Therapeutics LLC

13 patents
US10940139B2Mar 9, 2021

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC3 citations83
US10870657B2Dec 22, 2020

Compounds for the treatment of cancer and inflammatory disease

SHY Therapeutics LLC4 citations83
US10588894B2Mar 17, 2020

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC4 citations83
US10221191B2Mar 5, 2019

Compounds for the treatment of cancer and inflammatory disease

SHY Therapeutics LLC5 citations83
US12168668B2Dec 17, 2024

Compounds for the treatment of cancer and inflammatory disease

SHY Therapeutics LLC1 citations72
US11026930B1Jun 8, 2021

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC2 citations72
US11000515B2May 11, 2021

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC2 citations72
US10933054B2Mar 2, 2021

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC2 citations72
US12391705B2Aug 19, 2025

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC1 citations63
US11560390B2Jan 24, 2023

Compounds for the treatment of cancer and inflammatory disease

SHY Therapeutics LLC0 citations62
US11541041B1Jan 3, 2023

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease

SHY Therapeutics LLC0 citations61
US11213515B1Jan 4, 2022

Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC0 citations61
US12459951B2Nov 4, 2025

Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

SHY Therapeutics LLC0 citations45

CYBER SWITCHING INC

8 patents

CYBERSWITCHINGPATENTS LLC

4 patents

CYBER SWITCHING SOLUTIONS INC

4 patents

JANSSEN PHARMACEUTICA NV

4 patents

ROHM & HAAS

3 patents

MADRIGAL PHARMACEUTICALS INC

2 patents

COM DANGLES LLC

2 patents

BAXTER ELLEN

2 patents

REYNOLDS CHARLES H

1 patent

(unassigned)

1 patent

JANSSSEN PHARMACEUTICA N V

1 patent